Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.

MLA

Korsen, Joshua A., et al. “Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 63, no. 9, Sept. 2022, pp. 1401–07. EBSCOhost, https://doi.org/10.2967/jnumed.121.263221.

APA

Korsen, J. A., Kalidindi, T. M., Khitrov, S., Samuels, Z. V., Chakraborty, G., Gutierrez, J. A., Poirier, J. T., Rudin, C. M., Chen, Y., Morris, M. J., Pillarsetty, N., & Lewis, J. S. (2022). Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 63(9), 1401–1407. https://doi.org/10.2967/jnumed.121.263221

Chicago

Korsen, Joshua A, Teja M Kalidindi, Samantha Khitrov, Zachary V Samuels, Goutam Chakraborty, Julia A Gutierrez, John T Poirier, et al. 2022. “Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 63 (9): 1401–7. doi:10.2967/jnumed.121.263221.